- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
R&G PharmaStudies Co Ltd (301333)R&G PharmaStudies Co Ltd stock price live, this page displays SZ 301333 stock exchange data. View the 301333 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the R&G PharmaStudies Co Ltd real time stock price chart below.
What Is the R&G PharmaStudies Co Ltd Stock Price Today?
The R&G PharmaStudies Co Ltd stock price today is 57.19.
What Is the Stock Symbol for R&G PharmaStudies Co Ltd?
The stock symbol for R&G PharmaStudies Co Ltd is "301333."
What Stock Exchange Does R&G PharmaStudies Co Ltd Trade On?
R&G PharmaStudies Co Ltd is listed and trades on the Shenzhen stock exchange.
Is R&G PharmaStudies Co Ltd a Good Stock to Buy?
Determining whether R&G PharmaStudies Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 301333 quote. (ISIN: CNE100005K44)
What Is the R&G PharmaStudies Co Ltd Stock Price Today?
The R&G PharmaStudies Co Ltd stock price today is 57.19.
What Is the Stock Symbol for R&G PharmaStudies Co Ltd?
The stock symbol for R&G PharmaStudies Co Ltd is "301333."
What Stock Exchange Does R&G PharmaStudies Co Ltd Trade On?
R&G PharmaStudies Co Ltd is listed and trades on the Shenzhen stock exchange.
Is R&G PharmaStudies Co Ltd a Good Stock to Buy?
Determining whether R&G PharmaStudies Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 301333 quote. (ISIN: CNE100005K44)
Shenzhen
Currency in CNY
57.19
-0.61(-1.06%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
56.35
57.98
52 wk Range
33.05
73.08
301333 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
56.3557.98
52 wk Range
33.0573.08
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.35%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.35%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
301333 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
59.50
Upside
+4.04%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
R&G PharmaStudies Co Ltd Company Profile
R&G PharmaStudies Co., Ltd. provides clinical research outsourcing services for pharmaceutical and medical device companies, and scientific research institutions in China. It offers clinical trial consulting, clinical trial operation, data management and statistical analysis, technical services and solutions, biostatistical quantitative scientific support, and various services related to the clinical trial data monitoring committee, including participating in the committee or relevant statistical analysis for the committee. The company also provides clinical pharmacology services; biological sample testing services to analyze and detect the biological samples collected during the clinical trial, and to determine the concentration of the original drug and/or metabolites; and clinical trial site management services. The company was founded in 2008 and is based in Beijing, China.
Compare 301333 to Peers and Sector
Metrics to compare | 301333 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship301333PeersSector | |
|---|---|---|---|---|
P/E Ratio | 45.6x | 27.0x | −0.6x | |
PEG Ratio | −11.16 | −1.38 | 0.00 | |
Price/Book | 3.1x | 2.8x | 2.6x | |
Price / LTM Sales | 7.3x | 4.5x | 3.2x | |
Upside (Analyst Target) | 2.9% | 10.9% | 40.6% | |
Fair Value Upside | Unlock | 13.1% | 7.1% | Unlock |
Analysts' Recommendations
4 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 59.50
(+4.04% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.55
Dividend Yield
0.35%
Industry Median 0.62%
Annualized payout
0.2000
Paid annually
5-Years Growth
-
Growth Streak
FAQ
What Is the R G PharmaStudies (301333) Stock Price Today?
The R G PharmaStudies stock price today is 57.19
What Stock Exchange Does R G PharmaStudies Trade On?
R G PharmaStudies is listed and trades on the Shenzhen stock exchange.
What Is the Stock Symbol for R G PharmaStudies?
The stock symbol for R G PharmaStudies is "301333."
Does R G PharmaStudies Pay Dividends? What’s The Current Dividend Yield?
The R G PharmaStudies dividend yield is 0.35%.
What Is the R G PharmaStudies Market Cap?
As of today, R G PharmaStudies market cap is 5.58B.
What is R G PharmaStudies Earnings Per Share?
The R G PharmaStudies EPS is 1.55.
From a Technical Analysis Perspective, Is 301333 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.